News
IRTC
119.23
+1.14%
1.34
SOPHiA GENETICS SA (SOPH) Surges 13.0%: Is This an Indication of Further Gains?
NASDAQ · 6d ago
iRhythm Technologies Affirms Fiscal 2023 Guidance; Chief Operating Officer to Resign
iRhythm Technologies Affirms Fiscal 2023 Guidance; Chief Operating Officer to Resign
MT Newswires · 03/16 10:35
Morgan Stanley Reaffirms Their Buy Rating on Irhythm Technologies (IRTC)
TipRanks · 03/16 09:35
iRhythm Technologies reaffirms fiscal 2023 financial guidance
Seeking Alpha · 03/15 21:50
BRIEF-Irhythm Technologies Inc - On March 15, 2023, Co Reaffirmed Its Financial Guidance For The Fiscal Year 2023
Reuters · 03/15 21:15
iRhythm Technologies Announced Douglas Devine Resigned As Chief Operating Officer of the Company
Benzinga · 03/15 21:14
iRhythm Technologies (IRTC) Soars 3.9%: Is Further Upside Left in the Stock?
NASDAQ · 03/14 11:42
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
Benzinga · 03/11 19:27
iRhythm Technologies Says Co Has ~$54.5M In Operating Accounts At SVB; Co Had Cash, Cash Equivalents Of $213.1M As Of Dec. 31, 2022
Benzinga · 03/10 23:05
BRIEF-iRhythm Technologies Inc Has A $35 Mln Term Loan Outstanding With SVB
Reuters · 03/10 22:36
Insider Sell: Irhythm Technologies
Insider Sell: Irhythm Technologies
MT Newswires · 03/07 14:16
Analysts’ Top Healthcare Picks: Lumos Pharma (LUMO), Irhythm Technologies (IRTC)
TipRanks · 03/02 13:40
iRhythm Technologies Earnings Perspective: Return On Capital Employed
Benzinga · 02/28 14:49
iRhythm's Q4 Earnings Beat Expectations, Analysts Remain Bullish On Upcoming Catalysts
Benzinga · 02/24 17:44
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Irhythm Technologies (IRTC), Incyte (INCY) and Humana (HUM)
TipRanks · 02/24 16:20
Canaccord Genuity Maintains Buy on iRhythm Technologies, Raises Price Target to $143
Benzinga · 02/24 14:47
Morgan Stanley Maintains Overweight on iRhythm Technologies, Raises Price Target to $130
Benzinga · 02/24 13:04
Irhythm Technologies (IRTC) Receives a Buy from Needham
TipRanks · 02/24 12:25
Canaccord Genuity Adjusts iRhythm Technologies' Price Target to $143 From $135, Keeps Buy Rating
Canaccord Genuity Adjusts iRhythm Technologies' Price Target to $143 From $135, Keeps Buy Rating
MT Newswires · 02/24 12:16
Where iRhythm Technologies Stands With Analysts
Benzinga · 02/24 12:01
More
Webull provides a variety of real-time IRTC stock news. You can receive the latest news about Irhythm Technologies Inc through multiple platforms. This information may help you make smarter investment decisions.
About IRTC
iRhythm Technologies, Inc. is a digital healthcare company that is engaged in providing ambulatory electrocardiogram (ECG) monitoring for patients for arrhythmias. The Company has developed a portfolio of ambulatory cardiac monitoring services on a platform, called the Zio service. Zio service consists of wearable patch-based biosensors, Zio XT and Zio AT monitors, which records and stores ECG data from every patient heartbeat for up to 14 consecutive days. Zio service then provides cloud-based analysis of the recorded cardiac rhythms using its algorithms, an assessment review of the data by its cardiographic technicians, a report called Zio report, which includes the summary of findings and finally its cloud-based digital information system, ZioSuite, allows clinicians to connect via a Web browser or mobile application for online report interpretation and clinical workflows. The Company's cloud-based data analytic platform to help physicians monitor patients and diagnose arrhythmias.